Enterprise Learning Strategy and Operational Launch Support

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00258

NAICS

541611 - Administrative Management and General Management Consulting Services

Classification Code

U009

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
The U.S. Food and Drug Administration (FDA), through its Office of Human Capital Management (OHCM), is preparing to award a sole source, firm-fixed-price contract for Enterprise Learning Strategy and Operational Launch Support. This procurement, identified under solicitation number 75F40126Q00258, is classified under NAICS code 541611 (Administrative Management and General Management Consulting Services) and Product Service Code U009. The anticipated period of performance is a one-year base, with all work to be performed within the United States. The primary objective of this contract is to support the FDA’s ongoing transition from a decentralized to a coordinated enterprise learning model. Historically, various FDA Centers, Offices, and Programs (COPs) have independently managed workforce training and professional development activities. The Agency is now centralizing these functions under OHCM to enhance efficiency, reduce duplication, and ensure alignment with federal workforce policies and FDA priorities. The contractor will be tasked with evaluating existing learning programs and developing structured frameworks, governance models, and operational processes to enable effective enterprise learning management across the Agency. Key requirements and expected deliverables include: - Comprehensive assessment of current FDA learning and development programs - Development of structured frameworks and governance models for enterprise learning - Design and implementation of operational processes to support centralized learning management - Recommendations to improve efficiency, reduce duplication, and ensure compliance with federal workforce policies This procurement is being conducted as a noncompetitive action, with the FDA intending to award the contract to GOVALLIES LLC, located at 301 S Vine St Ste 13, Urbana, Illinois 61801. The decision to pursue a sole source award is based on market research in accordance with FAR Part 10, which determined that GOVALLIES LLC possesses unique capabilities, immediate availability, and specialized institutional knowledge necessary to meet the FDA’s time-sensitive mission requirements. The Agency has concluded that soliciting competition would result in substantial duplication of cost and unacceptable delays. This notice is issued as a presolicitation and is not a request for competitive proposals. Interested parties should note that the opportunity is not open for competition due to the specialized nature of the requirement and the findings of the market research. The contracting activity is managed by the FDA Office of Acquisition and Grant Services, under the Department of Health and Human Services. For further information, the primary point of contact is Amanda Lusk ([email protected]), with Nicholas Bisher ([email protected]) as the secondary contact. Additional details, including the official notice and any updates, can be found on SAM.gov under Opportunity ID ec65347aa78c40dc892c6e9d38684535. This procurement represents a strategic initiative to modernize and unify the FDA’s approach to workforce development, with long-term benefits expected in operational efficiency, policy compliance, and the professional growth of FDA personnel.